Pereira Brian JG
SEC insider (Form 3/4/5 filer). CIK 0001298146. Director at PROKIDNEY CORP. (PROK) and 1 other issuer. 25 reported Form 4/5 transactions since Sep 2024; latest on Aug 20, 2026. Located in WINSTON SALEM, NC.
Companies Pereira Brian JG has filed insider reports for
- PROKIDNEY CORP. (PROK): Director
- KalVista Pharmaceuticals, Inc. (KALV): Director
Pereira Brian JG
CIK: 0001298146
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (25 total)
- Aug 20, 2026PROK
PROKIDNEY CORP.
SaleIndirect222.9K shares at avg. $1.42$317K - Aug 20, 2026PROK
PROKIDNEY CORP.
SaleDirect27.1K shares at avg. $1.42$38K - Aug 19, 2026PROK
PROKIDNEY CORP.
SaleIndirect222.9K shares at avg. $1.44$321K - Aug 19, 2026PROK
PROKIDNEY CORP.
SaleDirect27.1K shares at avg. $1.44$39K - Aug 18, 2026PROK
PROKIDNEY CORP.
SaleIndirect229.3K shares at avg. $1.37$314K - Aug 18, 2026PROK
PROKIDNEY CORP.
SaleDirect27.8K shares at avg. $1.37$38K - Aug 4, 2026PROK
PROKIDNEY CORP.
ConversionIndirect675.2K shares- - Aug 4, 2026PROK
PROKIDNEY CORP.
ConversionDirect81.9K shares- - Jun 11, 2026KALV
KalVista Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
14K shares- - Jun 11, 2026KALV
KalVista Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 20, 2026 |  PROK PROKIDNEY CORP. | Sale | 222,948 | $1.42 | $316,564 | Indirect |
| Aug 20, 2026 | PROK PROKIDNEY CORP. | Sale | 27,052 | $1.42 | $38,411 | Direct |
| Aug 19, 2026 | PROK PROKIDNEY CORP. | Sale | 222,949 | $1.44 | $321,203 | Indirect |
| Aug 19, 2026 | PROK PROKIDNEY CORP. | Sale | 27,051 | $1.44 | $38,972 | Direct |
| Aug 18, 2026 | PROK PROKIDNEY CORP. | Sale | 229,338 | $1.37 | $314,468 | Indirect |
| Aug 18, 2026 | PROK PROKIDNEY CORP. | Sale | 27,826 | $1.37 | $38,155 | Direct |
| Aug 4, 2026 | PROK PROKIDNEY CORP. | Conversion | 675,235 | - | $0 | Indirect |
| Aug 4, 2026 | PROK PROKIDNEY CORP. | Conversion | 81,929 | - | $0 | Direct |
| Jun 11, 2026 |  KALV KalVista Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 14,000 | - | - | Direct |
| Jun 11, 2026 | KALV KalVista Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 7,000 | - | - | Direct |
1-10 of 25 transactions